Share of Moderna COVID-19 vaccines delivered by country income group 2021

Published by
Matej Mikulic,
Nov 12, 2021
As of September 6, 2021, high-income countries accounted for around 84 percent of total Moderna vaccines delivered worldwide. Moderna delivered none of its vaccines to low-income countries, at all. The statistic illustrates the share of Moderna COVID-19 vaccines delivered worldwide, by country income group.

Share of Moderna COVID-19 vaccines delivered worldwide as of September 2021, by country income group

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

September 2021

Region

Worldwide

Survey time period

as of September 6, 2021

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Coronavirus (COVID-19): vaccines and vaccination campaign "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Coronavirus (COVID-19): vaccines and vaccination campaign

Pandemic situation

5

Search for vaccines

7

Leading products and companies

7

Vaccination campaign

5

Distribution inequality

5

Vaccination approval and willingness

8

Further Content: You might find this interesting as well

Topics

Global pharmaceutical industryPfizerBioNTechVaccinations in the U.S.Coronavirus disease (COVID-19) pandemic
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.